IBM's rare revenue warning sends shares plunging 25% — short the broken stock

Verdict: a short thesis wearing a long strategy's clothes — wait for confirmation

This idea is more confusing than convincing. The thesis argues for shorting IBM after its July 14, 2026 revenue warning sent shares down more than 25%, yet the deployed rule set is a long failed-breakdown re-entry whose five entry conditions all read as met at the $238.76 close. The strongest point for the trade is that the June 30, 2026 quarter contradicts the doom narrative — revenue of $17.2B rose 7.8%, net income jumped 78% to $2.17B, and debt-to-equity fell 6.8% to 1.63, giving dip-buyers a fundamental anchor. The strongest point against it is the cash picture: free cash flow fell 52% quarter-over-quarter to $2.37B, and the June 30, 2026 ownership window shows about $5.8M of net insider open-market selling — a lagged disclosure, but not a classic bottoming signal. The backtest adds humility: over 1,235 daily bars in 60 months the rules produced zero entries, and the parameter-sensitivity evaluation ended with no robust setup recommendation, so the published parameters are used as written rather than validated. If IBM's late-October Q3 report extends the Q2 recovery and the price holds the $233.75 gap base, the long works toward the roughly $250.2 target; a close below $233.75 kills it. Watch the next fundamentals filing after Q3 — free cash flow is the first number skeptics should check.

Trade now: all five entry checks read green — this is a staged long entry, not a chase

This is a long setup, whatever the headline says: the strategy is a failed-breakdown re-entry after the earnings plunge, and right now all five entry conditions read as met on live daily bars. IBM closed at $238.76, $4.51 above the 21-day EMA at $234.25. RSI (14) sits at 60.0, inside the required 45–65 band, the MACD histogram is above its signal line, and ADX (14) at 40.5 is comfortably above the 20 trend-strength floor. That means the entry is triggered on current data — no waiting required. One caution: the rules did not fire at any point in the last 60 months of bars, so this is a watch-list setup whose conditions are only now aligning, not a proven signal. Risk is explicitly bounded by the rule set. The invalidation stop is -2.4% from entry (roughly $233 at the current close, sitting just above the $233.75 first support level), and the first profit target is +4.8% (roughly $250.2), with an additional take-profit at the 127.2% extension and a 10-day time stop. That is an effective 2-to-1 reward-to-risk profile. Position sizing is fixed-risk at 2.4% of capital with a 25% maximum position size. What does waiting mean here? Only this: if you have not entered, do so only on a fresh daily bar where all five conditions still hold. A close back below the 21-day EMA at $234.25, or RSI slipping under 45, voids the entry. The stock is still 27.5% below its range high and 16% above its range low, so the gap base at $233.75 is the level that matters most — a close below it is an exit, not a dip to buy. One caveat on robustness: the parameter-sensitivity evaluation ran out of time and produced no robust setup recommendation, so the published parameters are used as written rather than optimized.

A 25% single-day break: why the short case has teeth

The catalyst is real and severe. Per the Yahoo Finance reports of July 14, 2026, IBM warned on Q2 revenue and the stock fell 22% pre-market, then more than 25% as the session developed. The thesis argues that a surprise revenue warning shatters trust and forces institutional repositioning that keeps pressure on for days — and the size of the move (a quarter of the company's value in one day) is consistent with a market that was genuinely blindsided rather than one digesting a well-telegraphed slowdown. The most recent…

Scores

• Conviction score breakdown: 53
• Thesis support: 45
• Trade readiness: 40
• Risk quality: 50
• Trigger proximity: 70
• Fundamentals trend: 60

Watch items

• IBM — Close vs 21-day EMA
• IBM — RSI (14)
• IBM — MACD histogram vs signal
• IBM — ADX (14)
• IBM — First support level (gap base)
• IBM — Unrealized P&L stop (2.4% risk)
• IBM — Q3 earnings report
• IBM — 13F institutional ownership filing
• IBM — Quarterly dividend per share
• IBM — Free cash flow (next XBRL report)